« Back to Record
Citation APA

Duerinck, J., D'Hondt, L., Joosens, E., Specenier, P. M., Verschaeve, V., Filleul, B., Vroman, P., Stragier, B., Rogiers, A., Clement, P. M. J. P., Bouttens, F., Andre, C., Neyns, B., Staelens, Y., Van Fraeyenhove, F., Baurain, J.-F., & Luce, S. (2015). Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma. Journal of neurology, 262(3), 742-751. doi:10.1007/s00415-014-7633-z


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/217552

Duerinck, J., D'Hondt, L., Joosens, E., Specenier, P. M., Verschaeve, V., Filleul, B., Vroman, P., Stragier, B., Rogiers, A., Clement, P. M. J. P., Bouttens, F., Andre, C., Neyns, B., Staelens, Y., Van Fraeyenhove, F., Baurain, J.-F., & Luce, S. (2015). Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma. Journal of neurology, 262(3), 742-751. doi:10.1007/s00415-014-7633-z